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Background: Acne is a common disorder of the human pilosebaceous unit, yet the mechanisms underlying
hyperkeratinisation and subsequent inflammation (comedogenesis) remain to be determined, although cutaneous
pathogens are implicated. Previously, it was reported that the release of the cytokine interleukin-1α (IL-1α) by
keratinocytes of the sebaceous duct was pivotal in the life cycle of the comedone, mediating both its development
and its spontaneous resolution. Toll-like receptors are a family of molecules that recognise pathogen associated
molecular patterns (PAMPs) presented by microorganisms, initiating a signalling cascade terminating in the release
of antimicrobial compounds and cytokines.
Methods: We used ex vivo sebaceous gland and primary monolayer keratinocyte culture, alongside ELISAs,
immunohistochemistry, Western blotting and RT-PCR to investigate the contribution of TLR activation to
acne pathogenesis.
Results: We found TLR2 to be expressed in basal and infundibular keratinocytes, and sebaceous glands, and its
activation provoked the release of IL-1α from primary human keratinocytes in vitro. The exposure of
microdissected human sebaceous glands to PAMPs specific for TLR2 in vitro resulted in a pattern of IL-1α like
cornification after seven days of exposure.
Conclusions: TLR activation and secretion of IL-1α from keratinocytes may be initiating steps in comedogenesis
and, therefore, critical to the pathophysiology of acne.
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Acne is characterized by the formation of comedones, but
the etiology of these lesions remains unclear, although cu-
taneous pathogens are most likely involved. High levels of
the pro-inflammatory cytokine IL-1α were reported in
acne lesions in vivo [1], and previous work revealed that
exposure of isolated infundibula and pilosebaceous units
to IL-1α in vitro induced comedone formation [2,3]. Be-
cause comedone formation reflects the development of in-
fundibular epidermal scaling, this finding is important
because it suggests that IL-1α, whose role in the epidermis
remains to be fully elucidated, is a mediator of scaling in
inflammatory skin disease. We sought to establish a link* Correspondence: joanne.selway@buckingham.ac.uk
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reproduction in any medium, provided the orbetween cutaneous flora, the release of IL-1α and the acne
life-cycle.
The epidermis provides the first line of defense against
invasion by pathogens. Whilst the epidermis contains
antigen-presenting Langerhans cells of the adaptive im-
mune system [4], keratinocytes also have inherent mecha-
nisms to combat infection. This innate immunity is a
remnant of an ancient host defense mechanism shared
with lower organisms, pre-dating adaptive immunity. The
activation of the prototypical innate Drosophila receptor
Toll is central to this innate response, leading to the re-
lease of antifungal factors [5]. A related family of Toll-like
receptors (TLRs) are widely expressed in mammalian tis-
sues, particularly epithelia, and growing body of research
indicates the importance of innate immunity in cutaneous
pathology [6-9]. Eleven mammalian Toll homologuesLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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discrete set of invariant moieties associated with in-
fectious agents called pathogen associated molecular
patterns, or PAMPs [10]. Notable PAMPs include pep-
tidoglycan (PGN) a component of the coats of gram-
positive bacteria (including P. acnes), lipopolysaccharide
(LPS) from gram-negative bacteria, or unmethylated
CpG DNA characteristic of viruses, which activate TLR2,
TLR4 and TLR9 respectively [reviewed in [11]]. PAMPs are
recognised by a leucine-rich extracellular TLR domain, ini-
tiating a signal transduction cascade via an intracellular
interleukin-1 receptor (IL-1R)-like region, characteristically
leading to the release of antibacterial compounds (β-
defensins and reactive oxygen species) and cytokines (in-
cluding IL-1α) via an NFκB-dependent mechanism [10,11].
There is much speculation regarding the source of infun-
dibular IL-1α in acne, and there are reports of release either
by keratinocytes [3,12,13] or by the cells of the immune sys-
tem [14,15]. Since IL-1α release is a consequence of TLR
signaling in many cell types including keratinocytes [10,13],
we wished to investigated if the exposure of sebaceous
glands maintained ex vivo to PAMPs induced hypercor-
nification via the TLR-stimulated release of IL-1α.
Methods
All materials were obtained from Sigma-Aldrich Ltd.
(Poole, UK), unless otherwise stated.
Tissue
Normal human mid-line chest skin was obtained from pa-
tients aged 48 to 76 yr undergoing cardiothoracic surgery
at Papworth Hospital (Huntington, UK). Sebaceous glands
were microdissected as previously described [16]. Both
University of Buckingham School of Science and Medicine
Ethical Committee approval and informed patient consent
were obtained. Tissues were either formalin fixed and par-
affin embedded for subsequent histological evaluation, or
used immediately for organ culture.
Organ and tissue culture
Normal human epidermal keratinocytes (NHEK, Invi-
trogen, Paisley, UK) were maintained in keratinocyte
serum free medium (Invitrogen, Paisley, UK) as stan-
dard. Sebaceous glands were maintained ex vivo on gelatine
sponges (Gelfoam, Upjohn, Kalamazoo, MI, USA) at 37°C
in a humidified 5% CO2: 95% air environment for 7 days in
William’s E medium (without phenol red), supplemented
with 2 mM L-glutamine, 500 ng/ml hydrocortisone, sodium
selenite (20 μM), triiodothyronine (10 nM), 1% trace elem-
ent mix (all supplements from Invitrogen), 11.1 mM glu-
cose, 10 μg/ml bovine pituitary extract, 100 U/ml penicillin,
100 μg/ml streptomycin and 2.5 μg/ml amphotericin B.
TLR agonists used in the organ culture experiments were
LPS (Cat. No. L8643), PGN (Cat. No. 77140), and LTA(Cat. No. L2515). Sebaceous glands were incubated in the
presence or absence of IL-1α (1 ng/μl), or relevant PAMPs
(25 μg/ml). Antibodies raised against human TLR2 and
TLR4 were obtained from HyCult Biotechnology bv (Uden,
Netherlands) and used at 100 μg/ml to block the effect of
the PAMPs. Organ culture experiments consisted of at least
3 biological replicates per treatment group, with at least
three glands studied from each donor.
RT-PCR
RNA was prepared from whole sebaceous glands or cul-
tured cells with TRI-reagent, and 1 μg total RNA was used
in first strand cDNA synthesis with random hexamers
(Pharmacia) according to the manufacturers’ recommen-
dations. 35 cycles of PCR (each of 94°C, 55°C and 72°C for
1 min) were performed as standard using specific primers




4 μm paraffin sections of chest skin derived from 10 different
male donors were dewaxed in Histoclear (National diagnos-
tics, Hull, UK) and rehydrated in graded ethanols prior to in-
cubation with an anti-TLR2 goat polyclonal antibody at 37°C
overnight at (sc-8690 used at 20 μg/ml, Santa Cruz, La Jolla,
USA). Specificity was evaluated by co-incubating primary
antisera with a five-fold excess of a Santa Cruz blocking pep-
tide (sc-8690 P, Santa Cruz, La Jolla, USA). Following incuba-
tion with an appropriate HRP-conjugated secondary
antiserum for 45 minutes at room temperature, slides were
developed with ImmPACT DAB peroxidase substrate
(Vector Laboratories, Peterborough, UK) according to the
manufacturer’s recommendations and counterstained with
haematoxylin before clearing in Histoclear and mounting in
VectaMount hardset mountant (Vector Laboratories, Peter-
borough, UK). Tissue sections were stained in triplicate and
samples from different individuals were stained contempor-
aneously to facilitate comparison.
IL-1α ELISA assays
IL-1α levels in 100 μl medium collected after 2 hr treatment
of pre-confluent NHEK with PGN (10 μg/ml) was assayed
by ELISA (MESOScale Discovery, Gaithersburg, MD) ac-
cording to the manufacturer’s recommendations. In order to
assess specificity, NHEK incubated with PGN and a ten-fold
excess (by mass) of a TLR2 neutralising antibody were in-
cluded in the study. All assays were performed in triplicate.
Western blotting
Pre-confluent primary keratinocytes were homogenised in
RIPA buffer (150 mM NaCl, 10 mM Tris-Cl pH7.2, 5 mM
EDTA, 0.1% SDS, 1.0% Triton-X100, 1.0% sodium
deoxcycholate, 1 mM phenylmethylsulphonylfluoride).
Figure 1 TLR Expression in vitro and in vivo. A) TLR2 expression was assessed by RT-PCR in cDNA prepared from HaCaT keratinocytes
(first lane), NHEK (second lane) or freshly-isolated human sebaceous glands (third lane, representative of ten different individuals). A no-template
cDNA control was included (fourth lane). B) TLR2 antisera were used to evaluate receptor localisation in skin isolated from ten individuals and
representative expression patterns are shown, with and without a blocking peptide (pep). Images were captured at 10 × original magnification.
Figure 2 TLR activation results in IL-1α release and NF-κB
activation. A) Preconfluent NHEK were treated with PGN in the
presence or absence of a TLR2 neutralising antibody, and levels of
IL-1α release determined by ELISA. B) Three separate cultures of
preconfluent NHEK were harvested following 90 min exposure to
PGN, and IκB expression relative to β-actin was determined by
Western blotting.
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cast bis-tris NuPage mini-gel (Invitrogen) and transferred
to PVDF membranes (Millipore) by wet electroblotting as
standard. Immunodetection was performed using an anti-
IκB polyclonal antibody (used at 1:1000 dilution, Santa
Cruz) and chemiluminescent detection (WesternBreeze,
Invitrogen) as recommended.
Results
TLR2 is expressed in human sebaceous glands
and keratinocytes
Expression of TLR2 mRNA in sebaceous glands from
ten individuals, as well as in normal human epidermal
keratinocytes (NHEK) and HaCaT keratinocytes, was
profiled by PCR (Figure 1A). Qualitatively, expression
of TLR2 was consistently found to be higher in primary
sebaceous gland tissue compared to isolated keratinocytes.
TLR expression characterises the human infundibulum
and basal interfollicular keratinocytes in situ
TLR2 immunoreactivity was evaluated in tissue isolated
from ten individuals, and representative patterns are
shown in Figure 1B. In the interfollicular epidermis,
expression was consistently most abundant in the basal
layer, and this predominantly basal pattern of im-
munolocalisation was also observed in infundibular
keratinocytes. The specificity of immunoreactivity was
confirmed by co-incubation with a specific TLR2 anti-
gen blocking peptide, following which no staining was
observed (Figure 1B).
IL-1α is released in response to TLR2 activation
TLR2 activation with PGN provoked the rapid release
of IL-1α from NHEKs (Figure 2A). PGN stimulated a
46% increase in IL-1α secretion relative to vehicle only
controls (p < 0.05). Moreover, the effect was specific as
the co-incubation of PGN with a TLR2 neutralisingantibody resulted in a significant reduction in IL-1α
levels in the media.PAMP-mediated TLR2 stimulation in NHEKs activates the
NFкB pathway
Western blotting was used to determine the degradation
of the NFκB repressor IκB in response to PAMP stimula-
tion of NHEK. A reduction in IκB signal in response to
PGN treatment was detected after two hours of PAMP
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of the TLR2 blocking antibody (Figure 2B).
PAMPs cause hypercornification in sebaceous glands
maintained ex vivo
The normal lobular structure of a freshly-isolated seba-
ceous gland is shown in Figure 3A, along with the
cornifying effects of 1 ng/μl IL-1α treatment for seven
days. A section of a comedone in situ is also shown.
Microdissected sebaceous glands were maintained in the
presence or absence of different TLR agonists (LTA,Figure 3 TLR activation promotes hypercornification in isolated huma
freshly-isolated and IL-1α treated sebaceous glands are shown, along with
experiments showing sebaceous glands treated with vehicle only (control)
incubated with a blocking antibody (block). All images are shown at 10 × oPGN and LPS) for seven days prior to histological ana-
lysis (Figure 3B) after which time hypercornification
(characteristic of acne lesions in vivo) was assessed.
Whilst there was some loss of structure in those organs
maintained for seven days in the presence of vehicle
alone, increased cornification was not detected. Expos-
ure to both PGN and LTA treatment resulted in pattern
of cornification similar to that observed following IL-
1α treatment, which was blocked following co-
incubation of PAMPs with a fourfold excess (by mass)
of a TLR2 neutralising antibody.n sebaceous glands maintained ex vivo. A) Histological sections of
an example of a comedone in situ. B) Morphology representative of 3
, TLR2 (LTA and PGN) or TLR4 agonists (LPS), or TLR agonists pre-
riginal magnification.
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sals such as P. aeruginosa (which act via TLR4 activa-
tion) and the exposure of isolated glands to LPS also
specifically-increased cornification, which was blocked
following co-incubation with an excess of a TLR4
neutralising antibody. All images are representative of
three different experiments.
Discussion
The expression of functional TLRs in both interfollicular
and infundibular human keratinocytes is consistent with
an innate role for these cells in the sensing of, and re-
sponse to, bacterial pathogens [17]. The majority of cu-
taneous pathogens are gram-positive and, therefore,
likely to initiate a response via TLR2. As P. acnes expos-
ure leads to increases in TLR2 (as well as TLR4) expres-
sion in NHEK, and TLR2 expression was reported
within acne lesions in situ [18], we choose to further in-
vestigate the role of this receptor in keratinocyte and se-
baceous gland function.
Although keratinocytes are known to express TLR2,
the precise compartmental localization of this receptor
in the epidermis is not clear [18-22]. Our observation of
predominantly basal localization of TLR2 in a range of
human skin samples agrees with the reports of both
Baker et al. [19] and Curry et al. [20], but some variation
between individuals, or indeed studies, would be ex-
pected (as reported by Pivarsci et al. [21] and Jugeau
et al. [18]) as these receptors are readily induced, not-
withstanding any genetic differences [23].
Viable stationary-phase P. acnes directly-activates NHEK
via TLR2, stimulating IL-1α release [12]. As the treatment
of NHEK with LTA and PGN was reported to trigger NFκB
activation via TLR2, in turn regulating the release of the
potent chemokine IL-8 [17,21], it is rational to investigate
the role of PAMPs in the pathogenesis of acne.
We found that the treatment of primary cultures of
keratinocytes with TLR2 agonists provoked the release ofFigure 4 A model of TLR activation and the life-cycle of acne. A) P. ac
keratinocytes to release inflammatory cytokines (ICs) including IL-1α via TLR
formation of the comedone. C) IC secretion, including IL-1α, is also associa
reducing the sebum levels and starving the P. acnes of nutrients. D) Reduc
and restoration of sebocyte maturation. Adapted from Downie MM et al. [3IL-1α, confirming our hypothesis and previously published
results [17,21]. This is likely to be a post-translational event
as previous observations indicated that stimulation with
micro-organisms (including P. acnes) was unable to stimu-
late the synthesis of IL-1α in keratinocytes [24,25]. In
addition, in our organ-maintained pilosebaceous units, we
were able to show that PAMP treatment led to a pattern
of hypercornification similar to that created by IL-1α
exposure (and, indeed, that seen in comedones in situ),
via both TLR2- and TLR4-dependent mechanisms. Fur-
thermore, normal morphology was maintained when
PAMP activity was neutralized with specific TLR blocking
antibodies. This suggests that PAMPs mediate their effects
on sebaceous glands via TLRs. The presence of a TLR2-
dependent innate immune response in sebocytes was pre-
viously documented [25,26], but the role of IL-1α, in
addition to that of lipid mediators such as free fatty acids,
is complex.
We recognize that the removal of organs from their
natural environment in our ex vivo model does not
allow us to investigate the contribution of the immune
system. This is an important consideration as the re-
sponse triggered by skin resident immune cells could
modulate the effect of PAMPs through both TLR-
dependent and TLR-independent mechanisms. That we
were able to provoke a response in normal human skin
(or at least skin without frank evidence of acne), which
is associated with a low level of infiltrating immune
cells, suggest that our model is able to recapitulate
comedogenesis, at least in part. One could also investi-
gate the role of TLR agonism in human sebocyte mono-
layer culture, or in sebaceous glands isolated from
individuals with acne, but we feel that our model pro-
vides a good compromise between biological relevance
and feasibility.
The role of pro-inflammatory cytokines in enhanced lipo-
genesis and acne pathogenesis is complex [24,25,27-32].
Increased sebum levels in adolescents, perhapsnes colonises the sebaceous gland and stimulates infundibular
activation. B) ICs, including IL-1α, stimulate hypercornification, thus
ted with a reduction in lipogenesis in basal sebocytes, thereby
tion in P. acnes levels reduces IC secretion, resolution of the comedone
].
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resulting from exposure to Western diets [30], may pro-
mote cutaneous P. acnes colonization [32]. Further-
more, other hormonal mediators may contribute to a
‘perfect storm’ of acne susceptibility. For example, ele-
vated IGF1 signaling can suppress the transcription of
anti-microbial peptides [33], thereby priming the innate
immune response. Thus, enhanced sebum levels, high
IGF1 signaling and free fatty acid availability could act in
concert to create a pro-inflammatory state primed for
comedogenesis [28]. Prominent in this pro-inflammatory
state is IL-1α [17,21], as well as other cytokines such as
TNFα [29,30].
Conclusions
We suggest that IL-1α release from infundibular keratino-
cyte in response to P. acnes- mediated TLR activation is an
important step in the complex natural history of the acne
lesion (Figure 4). Moreover, IL-1α may contribute to both
the creation of a comedogenic cytokine millieu, as well as
promoting the eventual sebocyte hypercornification charac-
teristic of acne lesions.
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